Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity.
A new genetic signature may help doctors predict outcomes and tailor treatment strategies for lung cancer patients.
This cohort study evaluates Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity. The PubMed abstract reports that We suggest that the MOMP-related signature established in this study may provide a reference for prognostic stratification in LUAD and offers candidate prognostic genes for subsequent experimental and clinical validation.
What the study was
- Study design
- Cohort study
- Population
- Human participants described in the PubMed abstract
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- 3 Biotech
Why it surfaced
Cohort study with human evidence; scored conservatively from PubMed abstract-level metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.